| Kidney Cancer Therapy Area Pipeline Report | | | | Each Therapy Area Pipeline Report also provides |
| contains detailed information on the kidney cancer | | | | detail on the top 20 companies with products in |
| drug pipeline. This report provides insight into the | | | | the early stage of development and the top 20 |
| pipeline status of kidney cancer drugs by | | | | companies with products in the late stage of |
| company and by stage as well as a summary of | | | | development. Finally, each report also provides a |
| the latest news and developments in this area. | | | | comparison with other major indications in the |
| Scope of the report: | | | | disease hub based on Marketed Products vs. |
| Each Life Science Analytics’ Therapy Area | | | | Pipeline Products. |
| Pipeline Report provides the user with real detail | | | | Key benefits |
| on drug pipelines, by company and by stage, for | | | | • Understand a company’s strategic |
| each specific therapy area. The latest news, by | | | | position by accessing detailed independent |
| company, also ensures that each report is fresh | | | | intelligence on its product pipeline for specific |
| and up-to-date. | | | | therapy areas. |
| In addition to new developments and disease | | | | • Keep track of your competitors and |
| specific pipeline projects, each report also contains | | | | partners by better understanding their product |
| extensive information in tabular format on a | | | | pipeline. |
| company’s full product pipeline and products | | | | • Monitor a company’s research |
| by phase of development with regard to the | | | | effectiveness by determining pipeline depth and |
| therapy area. | | | | number of products in development by clinical |
| Full pipeline details, by stage, are provided and | | | | phase for specific disease areas. |
| include detailed product descriptions, information | | | | • Maintain a critical competitive advantage. |
| on partnering activity plus clinical trial intelligence. | | | | |